For research use only. Not for therapeutic Use.
Levetiracetam-d6 is a deuterated form of levetiracetam, an antiepileptic drug commonly used to treat seizures. In this version, six hydrogen atoms are replaced with deuterium, enhancing its utility in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise tracking and analysis using mass spectrometry and NMR spectroscopy, facilitating detailed research into the drug’s absorption, distribution, metabolism, and excretion. Despite the isotopic substitution, Levetiracetam-d6 retains the same therapeutic properties as the non-deuterated form, making it valuable for research and clinical investigations.
| Catalog Number | C000245 |
| CAS Number | 1133229-29-4 |
| Synonyms | (αS)-α-(Ethyl-1,1,2,2,2-d5)-2-oxo-1-pyrrolidineacetamide-α-d; (-)-Levetiracetam-d6; Keppra-d6; Levesam 500-d6; UCB-L 059-d6 |
| Molecular Formula | C₈H₈D₆N₂O₂ |
| Purity | ≥95% |
| Solubility | Acetone (Slightly), Chloroform (Slightly), Methanol (Slightly) |
| Appearance | White to Pale Yellow Solid |
| Storage | -20°C, Inert atmosphere |
